Receptors, Dopamine D2Dopamine AgonistsDopamineReceptors, Dopamine D1PiribedilReceptors, DopamineDopamine AntagonistsBromocriptineReceptors, Dopamine D3ApomorphineDopamine AgentsQuinpiroleSpiperone2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineReceptors, Dopamine D4ErgolinesDopaminergic NeuronsReceptors, Dopamine D5Dopamine Plasma Membrane Transport ProteinsCorpus StriatumBenzazepinesRacloprideSalicylamidesSubstantia NigraDopamine Uptake InhibitorsTyrosine 3-MonooxygenaseMesencephalonSulpirideHaloperidolOxidopamineNeostriatumNucleus AccumbensNeuronsRats, Sprague-DawleyLevodopaCocaineDopamine beta-HydroxylaseDose-Response Relationship, DrugAmphetamineBehavior, AnimalDomperidoneMotor ActivityVentral Tegmental AreaParkinsonian Disorders1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineParkinson DiseaseDopamine and cAMP-Regulated Phosphoprotein 32TetrahydronaphthalenesHomovanillic AcidMPTP PoisoningBrainParkinson Disease, SecondaryCatalepsyCaudate NucleusPyrrolidinesMicrodialysisPutamenMethamphetamineAntipsychotic AgentsRadioligand AssayRewardAntiparkinson AgentsRats, WistarPrefrontal CortexDihydroxyphenylalanineFlupenthixolButaclamolVesicular Monoamine Transport ProteinsSerotoninBasal GangliaNicotinic AgonistsMice, Inbred C57BLYawningTropanesalpha-MethyltyrosineClozapineGABA Agonists1-Methyl-4-phenylpyridiniumPiperazinesAnalysis of VarianceAdrenergic Agents3,4-Dihydroxyphenylacetic AcidStereotyped BehaviorSynaptic TransmissionTegmentum MesencephaliLimbic SystemConditioning, OperantDrug InteractionsCentral Nervous System StimulantsSerotonin 5-HT1 Receptor AgonistsNerve Tissue ProteinsDyskinesia, Drug-InducedReceptor, Adenosine A2ANomifensineLisurideMice, KnockoutNuclear Receptor Subfamily 4, Group A, Member 2Time FactorsPergolideHyperkinesis